Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

January 30, 2018

Mit Philips, a health policy adviser at Doctors Without Borders/Médecins Sans Frontières (MSF), discusses the ongoing challenges left behind by the Ebola outbreaks in West Africa. View External Media.

December 01, 2017

Only 1 in 4 people living with HIV are receiving treatment in Guinea; without treatment, they can easily develop AIDS. Doctors Without Borders/Médecins Sans Frontières (MSF) supports a hospital in Conakry, Guinea, that treats those who have developed AIDS. Patients arrive very ill, often with opportunistic infections.

July 25, 2017

Greater global attention is needed to prevent and treat AIDS, as too many patients are dying despite the availability of antiretroviral treatment.

April 06, 2017

Less than a year after the official end of the Ebola outbreak, the Guinean health system continues to struggle.

March 17, 2017

October 21, 2016

More than two and a half years after the Ebola outbreak officially began, Doctors Without Borders/Médecins Sans Frontières (MSF) is closing projects in West Africa that had been specifically dedicated to caring for people who survived the disease.

June 08, 2016

The severity of the West Africa Ebola epidemic saw Doctors Without Borders/Médecins Sans Frontières (MSF) launch one of the largest emergency operations in its 44-year history.

May 20, 2016

Noah Traoré was the first person in the Tombolia neighborhood to have his finger pricked at the Doctors Without Borders/Médecins Sans Frontières (MSF) mobile clinic. "As the head of this neighborhood, I have to set an example," he says. "I love my community, so it is my duty to encourage them to protect themselves against HIV/AIDS."

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

January 14, 2016

By Luis Encinas, Doctors Without borders/Médecins Sans Frontières (MSF) Ebola expert 

After two years of epic struggle, the largest Ebola epidemic in history may finally be coming to an end. On January 15, if no new cases are recorded, Liberia will be the last country to be declared free of the Ebola virus in this epidemic.

Pages